Squawk Box


  • GM Q1 earnings mixed     Thursday, 24 Apr 2014 | 7:53 AM ET

    CNBC's Phil LeBeau and Chuck Stevens, CFO of General Motors, dissect the automaker's quarterly numbers. Stevens weighs in on how the recall scandal impacted the company's bottom line. Our recall charge is overshadowing our overall results, says Stevens.

  • I think this is going to be the corporate story of the year, says Austan Goolsbee, 32 Advisors strategic partner, discussing how the tech giant is likely to spend its cash.

  • GM's Q1 earnings beat the Street     Thursday, 24 Apr 2014 | 7:30 AM ET

    CNBC's Phil LeBeau breaks down the automaker's quarterly numbers of $0.06 EPS ex-items on revenues of $37.4 billion versus estimates of $38.40 billion.

  • Goolsbee: US corporate tax system messed up     Thursday, 24 Apr 2014 | 7:20 AM ET

    Austan Goolsbee, 32 Advisors strategic partner, discusses whether U.S. tax policy is prompting the recent spate of M&A activity in big corporations.

  • Kids' 'Squawk Planner'     Thursday, 24 Apr 2014 | 6:43 AM ET

    CNBC's Becky Quick and the "Little Squawkers," take a look at today's top business stories to watch.

  • Eli Lilly finds areas of strength: CFO     Thursday, 24 Apr 2014 | 7:07 AM ET

    Derica Rice, Eli Lilly CFO, reveals where Eli Lilly is finding areas of growth which include animal health, oncology, diabetes, and neuroscience.

  • FDA proposes e-cigarette regulations     Thursday, 24 Apr 2014 | 6:45 AM ET

    The FDA is considering new rules for e-cigarettes that are similar to those that currently govern tobacco products, reports NBC's Tom Costello.

  • S&P 500 target 1,950: Expert     Thursday, 24 Apr 2014 | 6:37 AM ET

    Michael Ryan, UBS, takes a look at the quality of first quarter earnings and the outlook on the S&P 500 this year. At the end of the day it's about corporate profits and earnings, says Ryan.

  • Apple beats the Street     Thursday, 24 Apr 2014 | 6:19 AM ET

    Dan Morgan, Synovus Trust, shares his thoughts on Apple's new products and 7-for-1 stock split.

  • GE in talks to buy Alstom: Report     Thursday, 24 Apr 2014 | 6:09 AM ET

    Nicholas Heyman, William Blair, discusses General Electric's possible acquisition of French train and power plant builder Alstom for more than $13 billion.

  • My Herbalife short is looking much better: Ackman Wednesday, 23 Apr 2014 | 12:09 PM ET
    An employee carries a box of products for shipment to a truck at the Herbalife Los Angeles distribution center in Carson, Calif.

    Bill Ackman tells CNBC that his losses from betting against Herbalife have been "more than cut in half" based on the recent downturn of the company's stock.

  • Too many Dunkin' Donuts?     Wednesday, 23 Apr 2014 | 8:55 AM ET

    Dunkin' Brands plans to have 1,000 stores in the Golden State, reports CNBC's Jane Wells with a look at the company's expansion plans.

  • Cramer: It wasn't front running     Wednesday, 23 Apr 2014 | 8:45 AM ET

    CNBC's Jim Cramer shares his thoughts on the legality of Bill Ackman's deal with Valeant to acquire Allergan, and why the SEC has an "existential crisis."

  • Will shareholders KO compensation plan?     Wednesday, 23 Apr 2014 | 8:32 AM ET

    Jason Subotky, Yacktman Funds, shares his thoughts on Coca-Cola's equity compensation plan. The problem with these plans are they are complicated and a lot of the details are not fully flushed out, says Subotky.

  • I did not front-run Allergan stock, Ackman says Wednesday, 23 Apr 2014 | 9:40 AM ET
    Bill Ackman

    Bill Ackman also tells CNBC that Allergan's poison-pill defense doesn't make his takeover bid more difficult.

  • Facebook is our top pick for 2014: Analyst     Wednesday, 23 Apr 2014 | 8:12 AM ET

    Anthony DiClemente, Nomura senior analyst, shares his upbeat outlook on the social media giant, as advertising dollars continue to shift towards digital media.

  • AT&T transforming customer base: CFO     Wednesday, 23 Apr 2014 | 8:04 AM ET

    John Stephens, AT&T CFO, delves into Ma Bell's quarterly numbers and weighs in on the company's strategy to increase its wireless subscribers.

  • William Ackman, Pershing Square Capital Management, explains how his partnership with Valeant is structured. And J. Michael Pearson, Valeant chairman & CEO, discusses why he partnered with Ackman instead of pursing Allergan alone. Creating shareholder value is our job, says Pearson.

  • Ackman: Allergan clear fit for Valeant     Wednesday, 23 Apr 2014 | 7:41 AM ET

    William Ackman, Pershing Square Capital Management, explains why he is helping Valeant buy Allergan.

  • J. Michael Pearson, Valeant Pharmaceuticals chairman & CEO, weighs in on news that Allergan has adopted a "poison pill" defense strategy. Also Pearson shares his thoughts on adding some of Allergan's notable cosmetic products like Botox and Restasis to its growing arsenal.

About Squawk Box

  • "Squawk Box" is the ultimate "pre-market" morning news and talk program, where the biggest names in business and politics tell their most important stories. Anchored by Joe Kernen, Becky Quick and Andrew Ross Sorkin, the show brings Wall Street to Main Street. It's a "must see" for everyone from the professional trader to the casual investor.

Contact Squawk Box


    Get the best of CNBC in your inbox

    › Learn More
  • Showtimes

    Weekdays 6a ET
    Weekdays 13:00 CET
    Weekdays 18:00 SIN/HK
    Weekdays 20:00 SYD
    New Zealand
    Weekdays 22:00 NZ


  • Joe Kernen is co-anchor of "Squawk Box," CNBC's signature morning program.

  • "Squawk Box" Co-Anchor

  • Andrew Ross Sorkin is a co-anchor of "Squawk Box," a financial columnist for "The New York Times" and the editor-at-large of NYT's DealBook.